Friday, September 24, 2004 5:23:03 PM
DNAP's market strategy (assuming that one exists)is totally irrelevant to what I have said.
If there was legitimate interest in the patents among the potential bidders, DNAP's position on the subject would be immaterial. The market would be aware of the interest and the stock price would reflect it.
As the secrets of the genome emerge and the historical changes that have shaped us into the beings that we are today are mapped and understood, the sum total of that understanding will be staggering. Any shortcut or technique that aids in the unlocking of those secrets will have a profound value. Every step in the evolutionary chain, every variation in the individual genome shares an ancestral link in our heritage. To some degree every minute variation in every individuals genome is by definition an 'Ancestry Indicator'. They will all have value in helping to understand the biological machine. All research in this field has the potential for 'value', scientific, cultural, medical etc.
To expect it all to have economic value, however, at this point requires a leap of faith. It is not supported by any reasonable evidence.
regards,
frog
BTW. FINITE is an interesting term. Three billion, for example, is a finite amount. lol
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM